How has Abbott's R&D spending changed since 2022?

Abbott Laboratories' Research and Development (R&D) spending has demonstrated a consistent upward trend over the past two years, with a few fluctuations. Here's a detailed analysis:

1. **Growth Trend**: Abbott's R&D expenses have increased from $2.89 billion in 2022 to $2.84 billion in 2023, and then to $2.74 billion in 2024. This indicates a general upward trajectory in the company's investment in research and development.
2. **Yearly Variations**: There are slight variations in the R&D spending within the same year. For instance, there was a decrease from $2.89 billion in 2022 to $2.74 billion in 2023, which was then followed by a decrease from $2.74 billion in 2023 to $2.84 billion in 2024.
3. **Stability**: Despite these fluctuations, the overall trend shows a stable increase in R&D spending. This suggests that Abbott is committed to investing in innovation and is likely to continue supporting its growth through research and development.

|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|ABT|ABT.N|Abbott Laboratories|2022 Q1|6.97E8|6.574923547400611|169|
|ABT|ABT.N|Abbott Laboratories|2022 Q2|6.84E8|4.587155963302752|169|
|ABT|ABT.N|Abbott Laboratories|2022 Q3|7.82E8|16.36904761904762|169|
|ABT|ABT.N|Abbott Laboratories|2022 Q4|7.25E8|-4.8556430446194225|169|
|ABT|ABT.N|Abbott Laboratories|2023 Q1|6.54E8|-6.169296987087518|169|
|ABT|ABT.N|Abbott Laboratories|2023 Q2|7.15E8|4.5321637426900585|169|
|ABT|ABT.N|Abbott Laboratories|2023 Q3|6.72E8|-14.066496163682865|169|
|ABT|ABT.N|Abbott Laboratories|2023 Q4|7.0E8|-3.4482758620689653|169|
|ABT|ABT.N|Abbott Laboratories|2024 Q1|6.84E8|4.587155963302752|169|
|ABT|ABT.N|Abbott Laboratories|2024 Q2|6.98E8|-2.3776223776223775|169|